<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04315363</url>
  </required_header>
  <id_info>
    <org_study_id>19-06-05</org_study_id>
    <nct_id>NCT04315363</nct_id>
  </id_info>
  <brief_title>Daily Activity Study of Health</brief_title>
  <acronym>DASH</acronym>
  <official_title>Daily Activity Study of Health in Older Sedentary Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northeastern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northeastern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this six-week behavioral intervention, sedentary older adults will receive daily health
      messaging via their smart phone to better understand their daily activities and emotions.
      Participants undergo structural and functional brain imaging before and after the
      intervention along with measures of their behavioral, emotional and thinking functions.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">August 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Daily activity</measure>
    <time_frame>Change in activity at six weeks compared to baseline</time_frame>
    <description>Participants' daily activity measured by wearable devices</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional and structural brain measures</measure>
    <time_frame>Change in structural and functional brain connectivity at six weeks compared to baseline</time_frame>
    <description>Functional (resting-state and task-based) and structural MRI brain measures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cognitive functioning</measure>
    <time_frame>Change in cognitive functioning at six weeks compared to baseline</time_frame>
    <description>Executive function, complex attention and processing speed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Affective processing</measure>
    <time_frame>Change in affective processing at six weeks compared to baseline</time_frame>
    <description>Measure of affect and mood (i.e., geriatric depression scale)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Aging</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Brain MRI and Motivational Behavioral Intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Brain MRI and Control Behavioral Intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Motivational MRI and Behavioral Intervention</intervention_name>
    <description>Motivational messaging delivered during a functional brain MRI scan and with daily messaging</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Control MRI and Behavioral Intervention</intervention_name>
    <description>Control messaging delivered during a functional brain MRI scan and with daily messaging</description>
    <arm_group_label>Active control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Being able to speak English fluently

          -  Body Mass Index (BMI) between 20 and 40

          -  Normal or corrected-normal vision based on the minimal 20/20 standard

          -  Ambulatory without pain or the assistance of walking devices

          -  No diagnosis of a neurological disease

          -  No contraindications to MRI imaging

          -  Exercising less than 75 minutes per week (half of the recommended 150 minutes per
             week)

          -  Regular access to a computer with internet or smartphone

        Exclusion Criteria:

          -  Current diagnosis of a Diagnostic and Statistical Manual of Mental Disorders (DSM-V)
             Axis I or II disorder including Major Depression

          -  History of major psychiatric illness including schizophrenia (not including general
             anxiety disorder or depression)

          -  Current treatment for cancer - except non-melanoma skin

          -  Neurological condition (multiple sclerosis, Parkinson's disease, dementia, mild
             cognitive impairment) or brain injury (traumatic or stroke)

          -  Type I Diabetes

          -  Current alcohol or substance abuse

          -  Current treatment for congestive heart failure, angina, uncontrolled arrhythmia, deep
             vein thrombosis or other cardiovascular event

          -  Myocardial infarction, coronary artery bypass grafting, angioplasty or other cardiac
             condition in the past year

          -  Current use of beta blockers

          -  Regular use of an assisted walking device

          -  Claustrophobia

          -  Not passing the Telephone Interview of Cognitive Status (TICS) as normal

          -  Use of any anti-psychotic, anti-depressant, anti-anxiety, and attention deficit
             disorder (ADD/ADHD) medications.

          -  Not fluent in English

          -  Contraindications to MRI

          -  No regular access to a computer with internet or smartphone
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maiya Geddes, Dr.</last_name>
    <phone>616259</phone>
    <phone_ext>2973</phone_ext>
    <email>mgeddes@bwh.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Meishan AI, BS</last_name>
    <phone>858265</phone>
    <phone_ext>7288</phone_ext>
    <email>ai.me@husky.neu.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northeastern University</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02120</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maiya Geddes, Dr.</last_name>
      <phone>616-259-2973</phone>
      <email>mgeddes@bwh.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Arthur Kramer, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susan Whitfield Gabrieli, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Charles Hillman, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>February 26, 2020</study_first_submitted>
  <study_first_submitted_qc>March 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2020</study_first_posted>
  <last_update_submitted>March 17, 2020</last_update_submitted>
  <last_update_submitted_qc>March 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northeastern University</investigator_affiliation>
    <investigator_full_name>Maiya Geddes</investigator_full_name>
    <investigator_title>Affiliate Associate Professor</investigator_title>
  </responsible_party>
  <keyword>motivation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

